EGFR and lung carcinoma: They played roles in mediating NSCLC cell proliferation, metastasis, and drug resistance by transactivating EGFR signaling [15, 24, 25], implying that the crosstalk between GPCR and EGFR may provide the opportunities to discover novel pharmacological approaches to treat lung cancer patients.